Review

1. Risk factors of portal vein thrombosis after splenectomy in patients with liver cirrhosis
2. Conventional type 1 dendritic cells in protective antitumor immunity and its potential in hepatocellular carcinoma
3. Stereotactic body radiation therapy for the management of HCC
4. The advances in immunotherapy for hepatocellular carcinoma
5. Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction
6. Comprehending the therapeutic effects of stereotactic body radiation therapy for small hepatocellular carcinomas based on imagings
7. Imaging assessment after SBRT for hepatocellular carcinoma

Original Article

1. β-catenin in intranuclear inclusions of hepatocellular carcinoma

Letter to Editor

1. For dietary advice in end-stage liver cirrhosis resting metabolic rate should be measured, not estimated